PUTNAM INVESTMENTS LLC - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 66 filers reported holding IMMUNE DESIGN CORP in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
PUTNAM INVESTMENTS LLC ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q4 2016$1,201,000
-37.5%
218,362
-13.8%
0.00%
-40.0%
Q3 2016$1,921,000
-16.7%
253,386
-10.4%
0.01%
-16.7%
Q2 2016$2,307,000
-37.4%
282,683
-0.3%
0.01%
-33.3%
Q1 2016$3,687,000
-34.9%
283,656
+0.6%
0.01%
-30.8%
Q4 2015$5,662,000
+64.0%
281,982
-0.4%
0.01%
+62.5%
Q3 2015$3,453,000
-40.6%
282,990
+0.5%
0.01%
-33.3%
Q2 2015$5,814,000281,5310.01%
Other shareholders
IMMUNE DESIGN CORP shareholders Q4 2016
NameSharesValueWeighting ↓
ProQuest Associates IV LLC 1,962,720$16,016,0006.52%
Abingworth LLP 197,300$1,610,0001.69%
NEXTHERA CAPITAL LP 85,138$695,0000.60%
Cormorant Asset Management, LP 432,990$3,533,0000.50%
SPHERA FUNDS MANAGEMENT LTD. 153,000$1,248,0000.32%
TFS CAPITAL LLC 102,685$838,0000.15%
RS INVESTMENT MANAGEMENT CO LLC 1,227,595$10,017,0000.10%
Eventide Asset Management 180,000$1,469,0000.09%
Focused Wealth Management, Inc 15,868$129,0000.06%
Spark Investment Management LLC 77,500$632,0000.06%
View complete list of IMMUNE DESIGN CORP shareholders